Table 2.
Type of surgery and tumour characteristics.
| Anastrozole n (%) | Fulvestrant n (%) | |
|---|---|---|
| Surgery | ||
| Breast-conserving surgery | 67 (60.4) | 56 (52.8) |
| Radical mastectomy | 44 (39.6) | 44 (41.5) |
| None | – | 6 (5.7) |
| pT | ||
| pT1/T2 | 100 (90.1) | 77 (72.6) |
| pT3/T4 | 9 (8.1) | 16 (15.1) |
| NA | 2 (1.8) | 13 (12.3) |
| pN | ||
| Negative | 54 (48.6) | 42 (39.6) |
| Positive | 55 (49.6) | 53 (50) |
| NA | 2 (1.8) | 11 (10.4) |
| Pathological responsea | ||
| Non-responder | 86 (77.5) | 80 (75.5) |
| Responder | 20 (18.0) | 14 (13.2) |
| NA | 5 (4.5) | 12 (11.3) |
| Allred ER score | ||
| 0–5 | 1 (0.9) | 18 (16.9) |
| 6–8 | 102 (91.9) | 72 (67.9) |
| NA | 8 (7.2) | 16 (15.2) |
| Ki-67 | ||
| ≤10% | 72 (64.9) | 65 (61.3) |
| >10% | 22 (19.8) | 21 (19.8) |
| NA | 17 (15.3) | 20 (18.9) |
| PEPI group | ||
| I and II (<4) | 56 (50.5) | 48 (45.3) |
| III (≥4) | 36 (32.4) | 30 (28.3) |
| NA | 19 (17.1) | 28 (26.4) |
TA combined with NA or NB and TB with NA or NB indicate an objective pathological response.
NA not available, PEPI preoperative endocrine prognostic index.
aaccording to the Sataloff classification.13
NA not available, PEPI preoperative endocrine prognostic index.